On the stock market since 1993, it operates in the world of money and finance. Now — the numbers.
The stock trades below its recent peak — about 15% off the top. A pullback, not a collapse.
It pays out $0.22 per share each year — regular cash for whoever holds the stock.
The balance sheet offers little cushion against a rough stretch. Report-card grade: 20/100.
On our five-subject report card, HRVIX sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: HRVIX is a high-risk stock — not yet profitable, and its future rides on its product catching on.